⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
From Dialogue to Direction: Advancing Collective Action in BIER's 20th Year
accessnewswire.com
ABBV
PEP
DEO
Nuevo informe: la enfermedad de Parkinson costó a EE.UU. $82,200 millones en 2024, superando proyecciones anteriores
prnewswire.com
ABBV
ACAD
New Report: In 2024, Parkinson's Disease Cost the U.S. $82.2 Billion, Surpassing Previous Projections
prnewswire.com
ABBV
ACAD
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
prnewswire.com
CLGN
ABBV
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
prnewswire.com
ABBV
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
prnewswire.com
ABBV
Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Metabolic Disorder Burden, Reports Mordor Intelligence
prnewswire.com
PFE
ABBV
Gilgamesh Pharma Closes Oversubscribed $60 Million Series A to Develop Next Generation Neuropsychiatric Therapies
prnewswire.com
ABBV
ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as Chief Financial Officer and Chief Business Officer
globenewswire.com
GS
BAC
ABBV
AbbVie Named Official Pharmaceutical Partner of Major League Baseball
prnewswire.com
ABBV